Marc A Pfeffer

发表

Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 x 2 tables with all available data but without artificial continuity correction.

Lu Tian, Tianxi Cai, L J Wei, 2009, Biostatistics.

Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme.

Salim Yusuf, Stuart J Pocock, Stefan D Anker, 2008, European heart journal.

Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure

Karl Swedberg, Salim Yusuf, Joanna Dobson, 2007, Circulation.

Cardiovascular Risk Associated With Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention

Marc A Pfeffer, Janet Wittes, A. Localio, 2005, The New England journal of medicine.

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.

Karl Swedberg, Salim Yusuf, Marc A Pfeffer, 2008, European heart journal.

Cardiorenal end points in a trial of aliskiren for type 2 diabetes.

Nish Chaturvedi, Akshay S. Desai, Marc A Pfeffer, 2012, The New England journal of medicine.

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

Karl Swedberg, Robert M Califf, Marc A Pfeffer, 2003, The New England journal of medicine.

Augmentation index and central aortic stiffness in middle-aged to elderly individuals.

Mitul Vyas, Marc A Pfeffer, M. Pfeffer, 2007, American journal of hypertension.

Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.

Salim Yusuf, Janice Pogue, Marc A Pfeffer, 2007, Journal of the American College of Cardiology.

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

Karl Swedberg, Salim Yusuf, Marc A Pfeffer, 2003, The Lancet.

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

Marc A Pfeffer, S. Solomon, M. Pfeffer, 2020, The New England journal of medicine.

Controversies in ventricular remodelling

Marc A Pfeffer, M. Pfeffer, B. Gersh, 2006, The Lancet.

Heart Failure With Preserved Ejection Fraction In Perspective.

Marc A Pfeffer, M. Pfeffer, A. Shah, 2019, Circulation research.

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.

Robert M Califf, Marc A Pfeffer, Eric J Velazquez, 2004, The New England journal of medicine.

New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes.

Giuseppe Ambrosio, Gerasimos S Filippatos, Frank Edelmann, 2014, European heart journal.

Adherence to medication according to sex and age in the CHARM programme

Inger Ekman, Karl Swedberg, Salim Yusuf, 2009, European journal of heart failure.

Heart failure

Marc A Pfeffer, M. Pfeffer, J. McMurray, 2005, The Lancet.

Comparison of regional versus global assessment of left ventricular function in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction: the valsartan in acute myocardial infarction echocardiographic study.

Marc A Pfeffer, Eric J Velazquez, S. Solomon, 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial

Jean-Claude Tardif, Marc A Pfeffer, Robert Small, 2008, The Lancet.

Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT Trial.

Yuliya Lokhnygina, Marc A Pfeffer, S. Solomon, 2007, European heart journal.

Cardiac-resynchronization therapy for the prevention of heart-failure events.

Wojciech Zareba, Arthur J Moss, Marc A Pfeffer, 2009, The New England journal of medicine.

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

Karl Swedberg, Salim Yusuf, Marc A Pfeffer, 2003, The Lancet.

Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial.

Min Zhang, Robert M Califf, Marc A Pfeffer, 2008, European heart journal.

Determinants of Elevated Pulse Pressure in Middle-Aged and Older Subjects With Uncomplicated Systolic Hypertension: The Role of Proximal Aortic Diameter and the Aortic Pressure-Flow Relationship

Marc A Pfeffer, M. Pfeffer, J. Izzo, 2003, Circulation.

Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

Christopher P Cannon, Marc A Pfeffer, A. Skene, 2004, The New England journal of medicine.

Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials.

Marc A Pfeffer, M. Pfeffer, M. Sabatine, 2008, Journal of the American College of Cardiology.

Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarction.

Hajime Uno, Chung-Lieh Hung, Marc A Pfeffer, 2010, Journal of the American College of Cardiology.

Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction).

Robert M Califf, Shelby D Reed, Marc A Pfeffer, 2014, JACC. Heart failure.

Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction.

Lemuel A Moyé, Marc A Pfeffer, G. Lamas, 2002, Journal of the American College of Cardiology.

Pulsatile hemodynamic effects of candesartan in patients with chronic heart failure: The CHARM Program

Elaine Warner, Marc A Pfeffer, M. Pfeffer, 2006, European journal of heart failure.

Variable Impact of Combining Fatal and Nonfatal End Points in Heart Failure Trials

Marc A Pfeffer, Jacobus Lubsen, S. Solomon, 2006, Circulation.

Omapatrilat Reduces Pulse Pressure and Proximal Aortic Stiffness in Patients With Systolic Hypertension: Results of the Conduit Hemodynamics of Omapatrilat International Research Study

Marc A Pfeffer, M. Pfeffer, J. Izzo, 2002, Circulation.

New therapeutic options in congestive heart failure: Part I.

Marc A Pfeffer, M. Pfeffer, J. McMurray, 2002, Circulation.

Predictors of mortality and morbidity in patients with chronic heart failure.

Salim Yusuf, Stuart J Pocock, Marc A Pfeffer, 2006, European heart journal.

Aortic Diameter, Wall Stiffness, and Wave Reflection in Systolic Hypertension

Marc A Pfeffer, M. Pfeffer, J. Izzo, 2008, Hypertension.

Left ventricular end-diastolic pressure and risk of subsequent heart failure in patients following an acute myocardial infarction.

Lemuel A Moyé, Marc A Pfeffer, G. Lamas, 2007, Congestive heart failure.

Predictors of Heart Failure in Patients With Stable Coronary Artery Disease: A PEACE Study

Marc A Pfeffer, Jean Rouleau, S. Solomon, 2009, Circulation. Heart failure.